AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.
After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.
I think a reversal is...
I have been looking at this pair since a while, one of my favourites.
I see a possible short (fast) trade in here, we touched the trendline and in the same moment, we touched 38% Fibonacci and a 4H resistance, just waiting on this last 2H candle closing in 1 hour.
Target at least the last low, from there we could take profit with half position and leave the...
